IGF-1 LR3

What Is IGF-1 LR3?

IGF-1 LR3 (Long R3 Insulin-like Growth Factor-1) is a synthetic analog of insulin-like growth factor-1 (IGF-1), a naturally occurring peptide involved in cellular signaling and growth-factor biology. It belongs to the insulin/IGF family of signaling molecules and was developed as a modified research analog to facilitate the study of IGF-1 receptor (IGF-1R)–mediated pathways under controlled laboratory conditions.

The molecule incorporates two structural modifications relative to native IGF-1: an arginine substitution at position 3 and a 13-amino-acid extension at the N-terminus. These modifications alter its interaction profile in experimental systems and have made IGF-1 LR3 a widely used tool in research involving receptor signaling, cellular communication pathways, and growth-factor biology.

In the scientific literature, IGF-1 LR3 is commonly investigated in cell-culture systems, mechanistic studies, and animal models examining IGF-1 receptor activation and downstream signaling networks. Researchers use the compound to explore how structural modifications to endogenous growth factors may influence receptor engagement, signaling duration, and pathway regulation in experimental settings.

Because IGF-1R signaling is involved in numerous biological processes, IGF-1 LR3 has been utilized in research spanning cellular signaling, molecular biology, metabolic pathway investigations, and growth-factor–associated regulatory systems. Its modified structure makes it particularly useful for comparative studies evaluating differences between native IGF-1 and engineered IGF analogs.

Most available findings originate from preclinical and laboratory research. While IGF-1 LR3 has been extensively studied as an experimental tool compound, controlled human clinical evidence remains limited. As such, observations involving IGF-1 LR3 should be interpreted strictly within a research framework and should not be extrapolated to clinical, therapeutic, or veterinary applications.

Bluum Peptides supplies IGF-1 LR3 as a high-purity, lyophilized research compound manufactured using controlled synthesis and purification processes. Each batch undergoes independent analytical verification to confirm identity and purity, with lot-specific Certificates of Analysis (COAs) available to support research reproducibility and data integrity.

IGF-1 LR3 is supplied strictly for research use only and is not intended for human consumption, therapeutic use, diagnostic use, or veterinary applications.

IGF-1 LR3 Mechanism of Action (Research Only)

IGF-1 LR3 is a synthetic analog of insulin-like growth factor-1 (IGF-1) studied for its interaction with the insulin-like growth factor-1 receptor (IGF-1R), a receptor tyrosine kinase involved in numerous cellular signaling pathways. In experimental systems, researchers use IGF-1 LR3 to investigate receptor-mediated signaling dynamics, growth-factor biology, and downstream intracellular communication networks.

Current mechanistic understanding is derived primarily from cell-culture studies, biochemical assays, and other preclinical research models. These observations should be interpreted strictly within controlled laboratory settings and do not establish clinical or therapeutic outcomes.

Structural and Chemical Basis

IGF-1 LR3 is a modified recombinant analog of human IGF-1 containing two structural changes relative to the endogenous peptide: an arginine substitution at position 3 and a 13-amino-acid extension at the N-terminus [1]. These modifications distinguish IGF-1 LR3 from native IGF-1 and contribute to its unique behavior in experimental systems.

Researchers frequently use modified growth-factor analogs such as IGF-1 LR3 to examine how structural alterations influence receptor interactions, signaling characteristics, and pathway activation under controlled laboratory conditions.

IGF-1 Receptor Signaling

A primary area of IGF-1 LR3 research involves activation of the insulin-like growth factor-1 receptor (IGF-1R) [2]. In experimental models, binding of IGF-1 LR3 to IGF-1R initiates receptor phosphorylation and subsequent intracellular signaling events associated with growth-factor communication pathways.

These systems allow investigators to study receptor activation, signal propagation, and regulatory mechanisms involved in IGF-1R-mediated cellular signaling.

Intracellular Signaling Pathways

Following IGF-1R activation, experimental studies have examined the involvement of signaling networks such as the PI3K/Akt and MAPK/ERK pathways [3]. These pathways are widely investigated in molecular biology because they participate in cellular communication, signal integration, and regulatory processes.

Researchers use IGF-1 LR3 as a tool to explore how receptor activation influences downstream signaling architecture, pathway interactions, and intracellular communication dynamics.

Growth Factor Biology and Cellular Communication

IGF-1 LR3 is frequently utilized in research examining growth-factor signaling and cellular regulatory networks. Experimental models investigate how IGF-1R activation influences cellular communication processes and how modified IGF analogs compare with endogenous signaling molecules [4].

This work contributes to a broader understanding of receptor-mediated signaling and the role of growth-factor pathways in complex biological systems.

Comparative IGF Signaling Research

Because of its structural modifications, IGF-1 LR3 is often studied alongside native IGF-1 and related growth-factor analogs. Comparative investigations examine differences in receptor interactions, signaling behavior, pathway activation profiles, and regulatory responses under controlled experimental conditions.

These studies help researchers better understand how modifications to naturally occurring signaling molecules may influence biological activity at the molecular and cellular levels.

IGF-1 LR3 is supplied strictly for laboratory research use and serves as a research tool for investigating IGF-1 receptor signaling, growth-factor biology, and intracellular communication pathways. It is not intended for human consumption, therapeutic use, diagnostic use, or veterinary applications.

IGF-1 LR3 Research Applications (Observations from Studies)

IGF-1 LR3 has been investigated in preclinical and translational research as a modified insulin-like growth factor analog used to study IGF-1 receptor (IGF-1R) signaling and growth-factor biology. Most available findings originate from cell-culture systems, mechanistic laboratory studies, and animal models designed to examine receptor-mediated signaling pathways under controlled experimental conditions.

The observations described below reflect experimental research findings and should be interpreted strictly within laboratory settings. They do not represent established clinical outcomes and should not be extrapolated to human or veterinary applications.

IGF-1 Receptor Signaling Research

One of the primary applications of IGF-1 LR3 research involves the study of IGF-1 receptor activation and downstream signaling networks. Researchers use experimental models to investigate how modified IGF analogs interact with IGF-1R and how receptor engagement influences intracellular communication pathways.

Because IGF-1 LR3 differs structurally from native IGF-1, it is frequently used in comparative studies examining how changes in ligand structure may affect signaling behavior and receptor-mediated responses under controlled laboratory conditions.

Cellular Growth-Factor Biology

IGF-1 LR3 is widely utilized in research involving growth-factor signaling and cellular communication processes. Experimental systems investigate interactions among receptor activation, intracellular signaling networks, and regulatory pathways associated with growth-factor biology.

These studies contribute to a broader understanding of how IGF-family signaling molecules participate in complex cellular communication systems and how modified analogs can be used to explore pathway regulation.

Metabolic Signaling Pathway Studies

Researchers have also examined IGF-1 LR3 in experimental models involving metabolic signaling pathways and receptor-mediated cellular communication. Because IGF-1R signaling intersects with numerous intracellular regulatory networks, these studies provide insight into how growth-factor signals are integrated within broader biological systems.

In laboratory settings, IGF-1 LR3 serves as a useful tool for investigating relationships among receptor activation, signal transduction pathways, and cellular regulatory mechanisms.

Comparative Growth Factor Research

A significant area of IGF-1 LR3 research involves comparisons with native IGF-1 and other growth-factor analogs. Researchers use these models to examine differences in receptor interactions, signaling profiles, pathway activation patterns, and regulatory responses.

Such comparative studies help researchers better understand how structural modifications influence growth-factor signaling and contribute to the development of experimental models for receptor biology research.

Signal Duration and Pathway Characterization

Because IGF-1 LR3 is structurally distinct from endogenous IGF-1, it is frequently used in studies examining signaling duration, pathway dynamics, and receptor-mediated communication processes. Researchers employ these systems to investigate how variations in ligand structure may influence signaling characteristics and downstream pathway behavior in experimental settings.

This ongoing body of research continues to support the use of IGF-1 LR3 as a valuable tool for studying IGF-1 receptor biology, growth-factor signaling, and intracellular communication pathways.

Bluum Peptides does not make or imply medical or therapeutic claims regarding IGF-1 LR3. All findings referenced here are derived from experimental and non-clinical research settings. This compound is supplied strictly for laboratory research use and is not intended for clinical, diagnostic, therapeutic, veterinary, or human applications.

IGF-1 LR3 vs IGF-1 DES vs Native IGF-1

Important Notice: Comparisons are provided strictly for research and modeling context, not for clinical equivalence or substitution.

IGF-1 LR3 Laboratory Safety & Handling

IGF-1 LR3 is supplied as a lyophilized research peptide and should be handled in accordance with established laboratory procedures for peptide-based research materials. Appropriate handling, storage, and documentation practices help maintain material integrity and support consistency across experimental workflows.

As a modified growth-factor analog, IGF-1 LR3 may be sensitive to environmental factors such as moisture, temperature fluctuations, excessive light exposure, and improper handling. Laboratory protocols should therefore be designed to minimize avoidable sources of degradation, contamination, and experimental variability.

Laboratory Handling Considerations

Best-practice laboratory guidance includes:

• Follow institutional standard operating procedures (SOPs), chemical hygiene plans, and approved research protocols.

• Wear appropriate personal protective equipment (PPE), including gloves, laboratory coat, and eye protection.

• Conduct weighing, preparation, and handling procedures in controlled laboratory environments where appropriate to minimize contamination and environmental exposure.

• Handle lyophilized material carefully to avoid unnecessary particulate dispersion during transfer or preparation.

• Use suitable laboratory equipment, containers, and documentation practices to support consistency and traceability.

• Record lot numbers, preparation details, storage conditions, and associated laboratory documentation to support reproducibility.

• Follow institutional procedures for spill response, waste management, and incident reporting.

These practices are particularly important in receptor-signaling, growth-factor biology, and cell-culture research, where material consistency can contribute to reliable experimental outcomes.

Storage and Stability Considerations

Appropriate storage conditions help preserve the integrity of lyophilized peptide materials during laboratory use.

• Store lyophilized material at approximately -4°F (-20°C), protected from light and moisture.

• For short-term handling, unopened material may be stored under refrigerated conditions (36–46°F / 2–8°C) when appropriate.

• Minimize repeated freeze-thaw cycles following reconstitution to reduce degradation-related variability.

• Maintain consistent storage conditions across experiments to support reproducibility.

• Clearly label prepared materials with relevant concentration, preparation date, and storage information.

• Inspect materials and associated documentation prior to use as part of routine laboratory quality-control procedures.

Careful storage and handling practices can help reduce avoidable sources of experimental variability and support consistency across research workflows.

Bluum Peptides supplies IGF-1 LR3 strictly for research use only. This material is not intended for human consumption, therapeutic use, diagnostic use, or veterinary applications and should be handled exclusively within qualified laboratory settings.

Certificate of Analysis (COA) & Quality Assurance

Each batch of IGF-1 LR3 supplied by Bluum Peptides is accompanied by a third-party–verified Certificate of Analysis (COA). These documents are provided to support research reproducibility, experimental transparency, and data integrity for researchers and institutions working with this modified IGF-1 analog.

For IGF-1 LR3, COAs typically include compound-relevant analytical data such as:

• Identity verification: Confirmation of the IGF-1 LR3 molecular structure using techniques such as mass spectrometry (MS) and/or NMR, appropriate for distinguishing modified IGF-1 analogs from native sequences.

• Purity analysis: Quantitative purity assessment, commonly via HPLC or comparable chromatographic methods, to support consistency in receptor signaling and growth-factor pathway studies.

• Peptide-specific characteristics: Reported molecular weight and sequence confirmation aligned with the extended and substituted structure of IGF-1 LR3.

• Physicochemical information: Available data related to solubility, concentration, or stability under defined laboratory testing conditions.

• Lot-specific documentation: Unique lot number, testing date, and analytical methodology summaries to support traceability and reproducibility.

Bluum Peptides works with independent, qualified analytical laboratories to perform third-party testing of IGF-1 LR3. This external verification process helps ensure objective assessment and consistent quality standards across production batches.

Certificates of Analysis are available in PDF format for review or upon request prior to purchase. Researchers are encouraged to retain COAs and associated batch records for internal audits, reproducibility documentation, and independent verification in accordance with institutional research protocols.

Scientific References

1. Assefa B, Mahmoud AM, Pfeiffer AFH, Birkenfeld AL, Spranger J, Arafat AM. Insulin-Like Growth Factor (IGF) Binding Protein-2, Independently of IGF-1, Induces GLUT-4 Translocation and Glucose Uptake in 3T3-L1 Adipocytes. Oxid Med Cell Longev. 2017;2017:3035184.
https://pmc.ncbi.nlm.nih.gov/articles/PMC5750484/ 

2. Alicia White, Jane Stremming, Stephanie R. Wesolowski, Saif I. Al-Juboori, Evgenia Dobrinskikh, Sean W. Limesand, Laura D. Brown, and Paul J. Rozance. IGF-1 LR3 does not promote growth in late-gestation growth-restricted fetal sheep. American Journal of Physiology-Endocrinology and Metabolism 2025 328:1, E116-E125
https://journals.physiology.org/doi/full/10.1152/ajpendo.00259.2024 

3. Baxter RC. Signaling Pathways of the Insulin-like Growth Factor Binding Proteins. Endocr Rev. 2023 Sep 15;44(5):753-778.
https://pmc.ncbi.nlm.nih.gov/articles/PMC10502586/ 

4. Khan MZ, Zugaza JL, Torres Aleman I. The signaling landscape of insulin-like growth factor 1. J Biol Chem. 2025 Jan;301(1):108047.
https://pmc.ncbi.nlm.nih.gov/articles/PMC11748690/